AlxplorerBio索智生物
AIxplorerBio provides AI-driven preclinical drug discovery and development for immunological and neurodegenerative diseases. It uses machine learning, computational biology, and data integration to identify and optimize drug candidates. The company operates in a B2B setting, partnering with pharma and biotech firms, and integrates with industry ecosystems and CROs. Core technology includes AI platforms, deep learning models, and collaboration with CROs like Viva Biotech. The aim is to accelerate R&D and scale through AI-driven paradigms across the drug discovery pipeline.
AlxplorerBio索智生物
AIxplorerBio provides AI-driven preclinical drug discovery and development for immunological and neurodegenerative diseases. It uses machine learning, computational biology, and data integration to identify and optimize drug candidates. The company operates in a B2B setting, partnering with pharma and biotech firms, and integrates with industry ecosystems and CROs. Core technology includes AI platforms, deep learning models, and collaboration with CROs like Viva Biotech. The aim is to accelerate R&D and scale through AI-driven paradigms across the drug discovery pipeline.